Zentalis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.564; its P/E ratio is -2.75; Zentalis Pharmaceuticals is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 900.00K	-	-	-	-
Gross Profit	$ 900.00K	-	-	-	-
EBIT	$ -60.78M	$ -55.51M	$ -99.47M	$ -60.84M	$ -54.51M
EBITDA	$ -60.65M	$ -57.23M	$ -102.34M	$ -63.74M	$ -56.65M
Net Income Common Stockholders	$ -60.92M	$ -62.74M	$ -112.53M	$ -63.22M	$ -54.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 482.92M	$ 516.64M	$ 552.99M	$ 392.52M	$ 437.37M
Total Assets	$ 551.69M	$ 585.72M	$ 621.44M	$ 489.34M	$ 539.31M
Total Debt	$ 43.15M	$ 43.27M	$ 44.03M	$ 44.77M	$ 45.17M
Net Debt	$ -439.77M	$ -473.37M	$ -508.96M	$ -347.75M	$ -392.20M
Total Liabilities	$ 114.30M	$ 103.82M	$ 98.16M	$ 103.68M	$ 105.29M
Stockholders Equity	$ 437.28M	$ 481.77M	$ 523.14M	$ 385.49M	$ 433.80M
Cash Flow	-
Free Cash Flow	$ -40.77M	$ -38.76M	$ -79.59M	$ -49.24M	$ -37.49M
Operating Cash Flow	$ -40.60M	$ -38.66M	$ -79.28M	$ -49.24M	$ -37.33M
Investing Cash Flow	$ -42.06M	$ -117.45M	$ 72.93M	$ 42.12M	$ -11.89M
Financing Cash Flow	-	$ 309.00K	$ 236.62M	$ 373.00K	$ 49.74M

Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

Income Statement >

Zentalis Pharmaceuticals Debt to Assets

Balance Sheet >

Zentalis Pharmaceuticals Cash Flow

Cash Flow >

Zentalis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing